IBD Research Group, Canberra Hospital, Canberra, Australia Australian National University Medical School, Canberra, Australia Australian National University Research School of Biology, Canberra, Australia.
IBD Research Group, Canberra Hospital, Canberra, Australia Australian National University Medical School, Canberra, Australia.
Gut. 2014 Oct;63(10):1596-606. doi: 10.1136/gutjnl-2013-305320. Epub 2014 Jan 15.
Our aim was to determine whether or not specific microorganisms were transported selectively to lymph nodes in Crohn's disease (CD) by comparing node and mucosal microbial communities in patients and controls. We also sought evidence of dysbiosis and bacterial translocation.
Lymph nodes, and involved and uninvolved mucosal samples were obtained from resections of 58 patients (29 CD, eight 'other inflammatory bowel disease' (IBD) and 21 non-IBD). Universal primers targeting V1-V3 regions of bacterial 16S rRNA genes were used to amplify bacterial DNA and amplicons sequenced using high throughput sequencing. 20 patients (eight CD (28%), two other IBD (25%) and 10 non-IBD (48%)) had PCR positive nodes.
All samples from an individual were similar: there was no evidence of selective concentration of any microorganism in nodes. No specific microorganism was present in the nodes of all CD samples. Escherichia/Shigella were common in all patient groups but patients with ileal CD had a greater proportion of Escherichia coli reads in their nodes than other CD patients (p=0.0475). Campylobacter, Helicobacter and Yersinia were uncommon; Mycobacterium and Listeria were not detected. Dysbiosis was present in all groups but shifts were specific and no common pattern emerged.
It is unlikely that a single bacterium perpetuates inflammation in late stage CD; dysbiosis was common and we found no evidence of increased bacterial translocation. We believe that future studies should focus on early disease and viable bacteria in nodes, aphthous ulcers and granulomas, as they may be more relevant in the initiation of inflammation in CD.
通过比较患者和对照者的淋巴结和黏膜微生物群落,确定特定微生物是否会选择性地被输送到克罗恩病(CD)的淋巴结中。我们还试图寻找微生物失调和细菌易位的证据。
从 58 例患者(29 例 CD、8 例“其他炎症性肠病”(IBD)和 21 例非 IBD)的切除物中获得淋巴结以及受累和未受累的黏膜样本。使用靶向细菌 16S rRNA 基因 V1-V3 区的通用引物扩增细菌 DNA,并使用高通量测序对扩增子进行测序。20 例患者(8 例 CD(28%)、2 例其他 IBD(25%)和 10 例非 IBD(48%))的淋巴结 PCR 阳性。
个体的所有样本均相似:没有证据表明任何微生物在淋巴结中有选择性浓缩。所有 CD 样本的淋巴结中均未发现特定微生物。大肠埃希菌/志贺菌在所有患者群体中均常见,但回肠 CD 患者的淋巴结中大肠埃希菌读数比例高于其他 CD 患者(p=0.0475)。弯曲菌、幽门螺杆菌和耶尔森菌少见;分枝杆菌和李斯特菌未检出。所有组均存在微生物失调,但移位是特异性的,没有出现共同模式。
不太可能有一种单一细菌在晚期 CD 中持续引发炎症;微生物失调很常见,我们没有发现细菌易位增加的证据。我们认为,未来的研究应集中在早期疾病和淋巴结、口疮性溃疡和肉芽肿中的活细菌,因为它们可能与 CD 中炎症的启动更相关。